Slingshot Biosciences Announces Rapid Expansion into the United Kingdom and European Union Markets
February 3, 2026
Life sciences innovator and leader in precision-engineered synthetic cell mimic technology expands its UK/EU operations to accelerate cell and gene therapy and pharmaceutical development EMERYVILLE, Calif. -- Slingshot Biosciences, the pioneer of synthetic cell mimic technology for flow cytometry controls, today announced its further expansion into the United Kingdom and European Union markets. This investment provides [...]
Phylo Introduces Biomni Lab, an Integrated Environment for AI-Native Biology
February 3, 2026
Backed by a $13.5M seed round co-led by Andreessen Horowitz and Menlo Ventures' Anthology Fund with Anthropic, Phylo is led by Stanford AI and biology researchers Kexin Huang, Ph.D. and Yuanhao Qu, Ph.D. SOUTH SAN FRANCISCO, Calif. -- Phylo, an applied AI research lab building technology to help biologists get more done, faster, today announced the [...]
February 3, 2026
Spectral Evolution, the leading provider of high-performance field-portable spectrometers and remote sensing solutions, is pleased to announce a new partnership with GWM Engineering, a well-established distributor of field-portable measurement and sampling instruments based in Finland. With more than 30 years of experience, GWM Engineering has built a strong reputation as a pioneer in the utilization [...]
February 3, 2026
SANTA CLARA, Calif., and BOSTON, Mass. -- Agilent Technologies, Inc. and Virscidian, LLC today announced an expanded collaboration to enhance interoperability between Agilent OpenLab CDS and Virscidian Analytical Studio. The solution enables scientists to seamlessly access chromatography data and orchestrate high-throughput workflows, including purification. It delivers greater efficiency for pharma and biopharma customers engaged in drug discovery, medicinal chemistry, and high-throughput [...]
February 3, 2026
Automation-Ready DNA extraction kit simplifies workflows, reduces errors, and delivers reproducible results across a diverse variety of sample types With the PS6399 kit, we provide our robust purification chemistry in a format optimized for high-throughput automated processing to meet the demands of modern research.” — Julie Baggs, Scientific Director ATLANTA, GA, UNITED STATES -- Omega Bio-tek, a [...]
SSI Diagnostica Group Acquires InDevR
February 3, 2026
SSI Diagnostica Group strengthens life science portfolio for vaccine development and quality control with acquisition of US-based multiplexing company Copenhagen -- SSI Diagnostica Group, a global company specializing in testing solutions for infectious diseases, has announced the acquisition of InDevR, a Colorado-based provider of advanced multiplexed solutions for vaccine testing and quality control. The addition strengthens [...]
IonOpticks appoints Darren Sher as Chief Commercial Officer to lead global commercial strategy
February 3, 2026
The appointment strengthens IonOpticks’ commercial leadership as the company scales its global operations. IonOpticks, a world-leading provider of liquid chromatography solutions, today announces the appointment of Darren Sher as Chief Commercial Officer; a strategic Executive role established to provide coordinated leadership across global sales, marketing, customer support, and aligned customer processes as the company continues [...]
BioIVT Appoints Dr. Auro Nair as Chief Executive Officer
February 2, 2026
WOODBURY, N.Y. -- BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced the appointment of Dr. Auro Nair as the company’s Chief Executive Officer. Dr. Nair has served on BioIVT’s Board of Directors since June 2024. “Dr. Nair brings deep life sciences experience, a drive for success, [...]
PacBio Completes Sale of Short-Read Sequencing Assets
February 2, 2026
MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received $48.1 million in net cash [...]
February 2, 2026
Fully defined, synthetic ECM designed to improve reproducibility and reduce lot-to-lot variability Supports standardization of scalable 3D stem cell and organoid workflows Synthetic alternative to traditional matrices, enabling consistent performance while aligning with regulatory and translational initiatives MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the [...]

